CTY
City Therapeutics, Inc. · NASDAQ:CTY
20.71 USD−1.43 −6.46%
City Therapeutics, Inc. (NASDAQ:CTY) last traded at 20.71 USD, down 6.46% on the day. Over the past year the stock is down 9.96%. Its 52-week range is 19.75 to 23.88. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open22.07
Day range20.37 – 22.26
52-week range19.75 – 23.88
Volume116.79 K
Average volume (10 days)262.39 K
Market cap1.07 B
Dividend yield0.00%
Performance
+0.44%1 week
−9.96%1 month
−9.96%3 months
−9.96%6 months
−9.96%Year to date
−9.96%1 year
Technical rating
Strong sell
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Latest headlines
- ARCH Venture Fund XII Discloses Investment in City Therapeutics with 25.6% StakeTradingView · 26 Oct 2026
- City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswire · 19 Oct 2026
- City Therapeutics, Inc. (CTY) Closes Upsized $230M IPO at $18TradingView · 19 Oct 2026
- RNAi drug developer City climbs after upsized IPOSeeking Alpha · 16 Oct 2026
- City Therapeutics Shares Leap in Trading Debut After Upsized IPODow Jones Newswires · 16 Oct 2026
- RNAi drugmaker City prices upsized IPO at $18 per shareSeeking Alpha · 16 Oct 2026
- City Therapeutics Upsized IPO Priced at Middle of ViewsDow Jones Newswires · 16 Oct 2026
- City Therapeutics Announces Pricing of Upsized Initial Public Offering >CTYDow Jones Newswires · 16 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.